Actinic keratosis: Current treatment options

American Journal of Clinical Dermatology

Volumn 1, Issue 3, 2000, Pages 167-179

  Jeffes III, Edward W B ^a   Tang, Emily H ^a  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; KERATOSIS; REVIEW;

HUMANS; KERATOSIS;

EID: 0034189556     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200001030-00004     Document Type: Review

References (52)

1. Olsen EA, Abernethy L, Kulp-Shorten C, et al. A double blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratosis on the head and neck. J Am Acad Dermatol 1991; 24: 738-43
2. Kirkham N. Tumors and cysts of the epidermis. In: Elder D, Elenitsas R, Jaworsky C, et al., editors. Lever's histopathology of the skin. Philadelphia: Raven, 1997: 701-5
3. Marks R, Ponford NW, Selwood TS, et al. Non-melanocytic skin cancer and solar keratosis in Victoria. Med J Aust 1983; 2: 619-22
4. Marks R, Foley P, Goodman G, et al. Spontaneous remission of solar keratosis: the case for conservative management. Br J Dermatol 1986; 115: 649-55
5. Marks R, Ronnie G, Selwood TS. Malignant transformation of solar keratosis to squamous cell carcinoma. Lancet 1988; I: 795-7
6. Marks R, Ronnie G, Selwood TS. The relationship of basal cell and squamous cell carcinomas to actinic keratosis. Arch Dermatol 1988; 124: 1039-42
7. Dodson JM, DeSpain J, Heweet JE, et al. Malignant potential of actinic keratoses and the controversy over treatment. Arch Dermatol 1991; 127: 1029-31
8. Lund HZ. How often does squamous cell carcinoma of the skin metastasize? Arch Dermatol 1965; 92: 635
9. Moller R, Reymann F, Hou-Jensen K. Metastases in dermatological patients with squamous cell carcinoma. Arch Dermatol 1979; 115: 703-5
10. Dufresne, RG, Curlin MU. Actinic chelitis: a treatment review. Dermatol Surg 1997; 23: 15-21
11. Baker SR. Risk factors in multiple carcinomas of the lip. Otolaryngol Head Neck Surg 1980; 88: 248-51
12. Jensen P, Hansen S, Moller, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40: 177-86
13. Bavinck JN, Hardie DR, Green A, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation 1996; 61:715-21
14. Bavinck JN, DeBoer A, Vermeer BJ, et al. Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients. Br J Dermatol 1993; 129: 242-9
15. Van Praag MC, Bavinick JN, Bergman W, et al. PUVA keratosis. A clinical and histopathologic entity associated with an increased risk of nonmelanoma skin cancer. J Am Acad Dermatol 1993; 28: 412-7
16. Engel A, Johnson M-L, Haynes SG. Health effects of sunlight exposure in the United States: results from the first national health and nutrition examination survey, 1971-4. Arch Dermatol 1988; 124: 72-9
17. Harvey I, Rankel S, Marks R, et al. Non-Melanoma skin cancer and solar keratoses. II. Analytical results of the South Wales skin cancer study. Br J Cancer 1996; 74: 1308-12
18. Kripke ML. Carcinogenesis: ultraviolet radiation. In: Freedber IM, Eisen AZ, Wolff K, et al. Fitzpatrick's dermatology in general medicine. New York: McGraw-Hill 1999: 465-72
19. Dlugosz AA, Yuspa SH. Carcinogenesis: chemical. In: Freedber IM, Eisen AZ, Wolff K, et al. Fitzpatrick's dermatology in general medicine. New York: McGraw-Hill 1999: 452-61
20. Lowy DR. Oncogenes and viral Carcinogenesis. In: Freedber IM, Eisen AZ, Wolff K, et al. Fitzpatrick's dermatology in general medicine. New York: McGraw-Hill, 1999: 461-5
21. Nomura T, Nakajima H, Hongyo T, et al. Induction of cancer, actinic keratosis, and specific p53 mutations by UVB light in human skin maintained in severe combined immunodeficient mice. Cancer 1997 57: 2081-4
22. Spencer JM, Kahn SM, Jiang W, et al. Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomas. Arch Dermatol 1995; 131: 796-800
23. Davis S, Capjack L. Clothing as protection from ultraviolet radiation: which fabric is most effective? Int J Dermatol 1997; 36: 374-9
24. Diffey BL, Cheeseman J. Sun protection with hats. Br J Dermatol 1992; 127: 10-2
25. Naylor MF, Boyd A, Smith DW, et al. High sun protection factor sunscreens in the suppression of actinic neoplasia. Arch Dermatol 1995; 131: 170-5
26. Ananthaswamy HN, Loughlin SM, Ullrich SE, et al. Inhibition of UV-induced p53 mutations by sunscreens: implications for skin cancer prevention. J Invest Dermatol Symp Proc 1998; 3: 52-6
27. Whitmore SE, Morison WL. Prevention of UVB-induced immunosuppression in humans by high sun protection factor sunscreen. Arch Dermatol 1995; 131: 1128-33
28. Black HS, Herd A, Goldberg LH, et al. Effect of a low-fat diet on the incidence of actinic keratosis. N Engl J Med 1994: 330: 1272-5
29. Black HS. Influence of dietary factors on actinically-induced skin cancer. Mutat Res 1998; 422: 185-90
30. Lubritz RR, Smolewski SA. Cryosurgery cure rate of actinic keratosis. J Am Acad Dermatol 1982; 7: 631-2
31. Goette DK. Topical chemotherapy with 5-fluorouracil. J Am Acad Dermatol 1981; 4: 633-49
32. Pearlman LD. Weekly pulse dosing: defective and comfortable topical 5-fluorouracil treatment of multiple facial actinic keratosis. J Am Acad Dermatol 1991; 25: 665-7
33. Epstein E. Does intermittent 'pulse' topical 5-fluorouracil therapy allow destruction of actinic keratoses without significant inflammation? J Am Acad Dermatol 1998; 38: 77-80
34. Robinson TA, Kligman AM. Treatment of solar keratoses of the extremities with retinoic acid and 5-fluororuacil. Br J Dermatol 1975; 92: 703
35. Bercovitch L. Topical chemotherapy of actinic keratosis of the upper extremity with tretinoin and 5-fluorouracil: a double-blind controlled study. Br J Dermatol 1987; 116: 549-52
36. Lawrence N, Cox SE, Clay J, et al. A comparison of the efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses. Arch Dermatol 1995; 131: 176-81
37. Coleman WP, Yarborough JM, Mandy SH. Dermabrasion for prophylaxis and treatment of actinic keratosis. Dermatol Surg 1996; 22 (1): 17-21
38. Sporn MB, Dunlop NM, Newton D, et al. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogues (retinoids). Fred Proc 1976; 35: 1332-8
39. Loton R. Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochim Biophys Acta 1980; 6 (5): 33-91
40. Moriarty M, Dunn J, Darragh A, et al. Etretinate treatment in actinic keratosis. Lancet 1982; I: 364-5
41. Hughes BR, Marks R, Pearse AD, et al. Clinical response and tissue effects of etretinate treatment of patients with solar keratosis and basal cell carcinoma. J Am Acad Dermatol 1988; 18: 522-9
42. Verret JL, Schnitzler L, Avenel M, et al. Etretinate and skin cancer prevention. A 6.5 year follow-up study. In: Saurat JH, editor. Retinoids: new trends in research and therapy. Basel: Karger, 1985: 355-60
43. Berretti B, Crupper CH. Cutaneous neoplasm and etretinate. In: Cunliffe WJ, Miller AJ, editors. Retinoid therapy. Lancaster: MTP, 1983: 187-95
44. Sander CA, Pfeiffer C, Kligman AM, et al. Chemotherapy for disseminated actinic keratoses with 5-fluorouracil and isotretinoin. J Am Acad Dermatol 1997; 36: 236-8
45. Majewski S, Skopinska M, Bollag W, et al. Combination of isotretinoin and calcitriol for precancerous and cancerous skin lesions [letter]. Lancet 1994; 344: 1510-1
46. Skopinska M, Majewski S, Bolleg W, et al. Calcitriol and isotretinoin combined therapy for precancerous cancerous skin lesions. J Dermatol Treat 1997; 8:5-10
47. Thianprasit M. Chronic cutaneous arsenism treated with aromatic retinoid. J Med Assoc Thailand 1984; 67: 93-100
48. Kligman AM, Thorne EG. Topical therapy of actinic keratoses with tretinoin. In: Marks R, editor. Retinoids in cutaneous malignancy. Oxford: Blackwell Scientific Publications, 1991: 66-73
49. Alireezai M, Dupuy P, Amblard P. Clinical evaluation of tropical isotretinoin in the treatment of actinic keratoses. J Am Acad Dermatol 1994; 30: 447-51
50. Jeffes EWB, McCullough JL, Weinstein CD, et al. photodynamic therapy of actinic keratoses with topical 5-aminolevulinic acid. A pilot dose-ranging study. Arch Dermatol 1997; 133: 727-32
51. Kurwa HA, Yong-Gee SA, Seed PT, et al. A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratosis. J Am Acad Dermatol 1999; 41: 414-8
52. Levulan Kerastick: FDA package insert. Wilmington (MA) 01887 DUSA Pharmaceuticals, Inc.